...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
【24h】

Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.

机译:在头颈部IMRT中基于直线加速器的头戴式2D检测器阵列的质量保证系统的临床介绍。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: IMRT QA is commonly performed in a phantom geometry but the clinical interpretation of the results in a 2D phantom plane is difficult. The main objective of our work is to move from film measurement based QA to 3D dose reconstruction in a patient CT scan. In principle, this could be achieved using a dose reconstruction method from 2D detector array measurements as available in the COMPASS system (IBA Dosimetry). The first step in the clinical introduction of this system instead of the currently used film QA procedures is to test the reliability of the dose reconstruction. In this paper we investigated the validation of the method in a homogeneous phantom with the film QA procedure as a reference. We tested whether COMPASS QA results correctly identified treatment plans that did or did not fulfil QA requirements in head and neck (H&N) IMRT. MATERIALS AND METHODS: A total number of 24 treatments were selected from an existing database with more than 100 film based H&N IMRT QA results. The QA results were classified as either good, just acceptable or clinically rejected (mean gamma index <0.4, 0.4-0.5 or >0.5, respectively with 3%/3mm criteria). Film QA was repeated and compared to COMPASS QA with a MatriXX detector measurement performed on the same day. RESULTS: Good agreement was found between COMPASS reconstructed dose and film measured dose in a phantom (mean gamma 0.83+/-0.09, 1SD with 1%/1mm criteria, 0.33+/-0.04 with 3%/3mm criteria). COMPASS QA results correlated well with film QA, identifying the same patients with less good QA results. Repeated measurements with film and COMPASS showed changes in delivery after a modified MLC calibration, also visible in a standard MLC check in COMPASS. The time required for QA reduced by half by using COMPASS instead of film. CONCLUSIONS: Agreement of COMPASS QA results with film based QA supports its clinical introduction for a phantom geometry. A standard MLC calibration check is sensitive to <1mm changes that could be significant in H&N IMRT. These findings offer opportunities to further investigate the method based on a 2D detector array to 3D dose reconstruction in a patient anatomy.
机译:背景与目的:IMRT QA通常在体模几何中执行,但是在2D体模平面中对结果进行临床解释很困难。我们工作的主要目标是在患者CT扫描中从基于胶片测量的质量保证过渡到3D剂量重建。原则上,这可以使用COMPASS系统中可用的2D检测器阵列测量中的剂量重建方法来实现(IBA剂量测定)。该系统代替当前使用的胶片QA程序进行临床引进的第一步是测试剂量重建的可靠性。在本文中,我们以胶片QA程序为参考,在均质体模中研究了该方法的有效性。我们测试了COMPASS QA结果是否正确确定了满足或不满足头颈部(H&N)IMRT QA要求的治疗计划。材料与方法:从现有数据库中选择了24种治疗方法,其中包含100多种基于H&N IMRT QA结果的胶片。质量检查结果分为良好,仅可接受或临床拒绝(以3%/ 3mm的标准分别表示平均伽玛指数<0.4、0.4-0.5或> 0.5)。重复胶片QA,并与当天进行的MatriXX检测器测量结果与COMPASS QA进行比较。结果:在幻像中,COMPASS重建剂量与胶片测量剂量之间发现了很好的一致性(平均伽玛0.83 +/- 0.09,1SD / 1%/ 1mm标准,0.33 +/- 0.04 3%/ 3mm标准)。 COMPASS QA结果与胶片QA密切相关,从而确定了QA结果较差的相同患者。用胶片和COMPASS进行的重复测量显示,经过修改的MLC校准后,输送发生了变化,这在COMPASS中的标准MLC检查中也可见。通过使用COMPASS而不是胶片,QA所需的时间减少了一半。结论:COMPASS QA结果与基于胶片的QA的一致性支持了其幻像几何的临床引入。标准的MLC校准检查对<1mm的变化很敏感,这在H&N IMRT中可能很重要。这些发现为进一步研究基于2D检测器阵列的方法进行患者解剖学3D剂量重建提供了机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号